Jakafi (ruxolitinib) - Incyte
Fulminant Gastrointestinal and Hepatic Graft-Versus-Host Disease Complicated by Refractory Colitis, Portal Hypertension, and Opportunistic Fungal Infection After Allogeneic Stem Cell Transplantation (ACG 2026) - Aug 29, 2026 - Abstract #P2584; Pres time: Oct 12, 2026; 10:30 AM - 04:15 PM; Location: Exhibit Halls A - D (Level 3); "Despite escalation of immunosuppression with corticosteroids and ruxolitinib, her course was complicated by multiorgan failure, including renal failure requiring continuous renal replacement therapy and refractory hemodynamic instability...Figure: Figure 2. Colonoscopic image demonstrating active gastrointestinal graft-versus-host disease (GVHD) with diffuse mucosal edema, erythema, friability, and loss of normal vascular architecture, consistent with severe colonic involvement." 
Acute Myelogenous Leukemia • Bone Marrow Transplantation • Cardiovascular • Chronic Graft versus Host Disease • Fibrosis • Gastroenterology • Gastrointestinal Disorder • Graft versus Host Disease • Hematological Malignancies • Hepatology • Immunology • Infectious Disease • Leukemia • Liver Failure • Myelodysplastic Syndrome • Novel Coronavirus Disease • Portal Hypertension • Transplantation
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=832179&rnd=0.9453158
 
Amro Alhouda MD 1; Jewairia Alajab MD 1; Abdallah Kheshman MD MPH 1; Rand Abdullatef MD 1; Abdelaziz Mohamed MBBS 2
 
Aug 29, 2026
 
Prev Next